Artal Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-700,000
| Closed | -$14.1M | – | 158 |
|
|
2021
Q3 | $14.1M | Sell |
700,000
-100,000
| -13% | -$2.02M | 0.32% | 62 |
|
|
2021
Q2 | $29.9M | Hold |
800,000
| – | – | 0.61% | 33 |
|
|
2021
Q1 | $20.5M | Buy |
+800,000
| New | +$20.5M | 0.36% | 53 |
|
|
2020
Q1 | – | Sell |
-500,000
| Closed | -$11M | – | 114 |
|
|
2019
Q4 | $11M | Sell |
500,000
-500,000
| -50% | -$11M | 0.43% | 39 |
|
|
2019
Q3 | $14.4M | Hold |
1,000,000
| – | – | 0.58% | 31 |
|
|
2019
Q2 | $15.8M | Buy |
1,000,000
+20,725
| +2% | +$326K | 0.64% | 27 |
|
|
2019
Q1 | $14.3M | Buy |
979,275
+454,275
| +87% | +$6.65M | 0.59% | 31 |
|
|
2018
Q4 | $5.61M | Buy |
525,000
+100,000
| +24% | +$1.07M | 0.21% | 44 |
|
|
2018
Q3 | $6.49M | Hold |
425,000
| – | – | 0.17% | 45 |
|
|
2018
Q2 | $5.21M | Hold |
425,000
| – | – | 0.11% | 47 |
|
|
2018
Q1 | $4.06M | Buy |
+425,000
| New | +$4.06M | 0.05% | 53 |
|